AUS
NZ
UK
CA
USA
IND
Health
Institutional Ownership Holds Key to CVS Health's Future
November 05, 2024 06:40 AM PST| By Team Kalkine MediaHeadlines,CVS Health’s ownership is dominated by institutional investors, holding 83% of shares.,Recent share value drops may pressure institutional investors to reconsider strategies.,Institutional investors could influence the future direction of C...
Vertex Pharmaceuticals Inc (VRTX) Q3 2024 Earnings Call Highlights Robust Revenue and Strategic Developments
November 05, 2024 02:53 AM PST| By Team Kalkine MediaHighlights:,Vertex Pharmaceuticals reports 12% year-over-year revenue growth in Q3 2024, reaching $2.77 billion.,The company increases full-year revenue guidance to a range of $10.8 billion to $10.9 billion, reflecting continued strong performance.,V...
Strong Revenue Growth Highlighted in Hologic Inc (HOLX) Q4 2024 Earnings Call
November 05, 2024 02:50 AM PST| By Team Kalkine MediaHighlights:,Hologic Inc. (HOLX) reports a 4.2% year-over-year growth in Q4 2024 total revenue, reaching $987.9 million.,The company demonstrates strong performance in its molecular diagnostics, breast health, and surgical segments, with notable growt...
Tempus (TEMP) Reports Healthy Q3 2024 Revenue Growth, Expands Testing Capabilities
November 04, 2024 08:27 PM PST| By Team Kalkine MediaHighlights:,Tempus reports 33% YoY revenue growth to $180.9M, driven by strong data services and genomics unit performance.,The company announces the acquisition of Ambry Genetics for $600M, expected to add over $40M in EBITDA.,Full-year 2024 revenue...
Viking Therapeutics Set for Strong Advancement on Recent Obesity Drug Findings
November 04, 2024 03:10 AM PST| By Team Kalkine MediaHighlights,Viking Therapeutics reported significant weight loss results from its experimental obesity pill VK2735 during the ObesityWeek conference.,Patients taking the highest dose of VK2735 lost an average of 8.2% of their body weight after 28 days...
A Share Adjustment in STERIS plc (NYSE:STE) Undertaken by US Bancorp DE
November 04, 2024 02:47 AM PST| By Team Kalkine MediaHighlights,US Bancorp DE reduced its stake in STERIS plc by 17.8% in the third quarter, reflecting strategic adjustments in portfolio management.,STERIS reported strong quarterly earnings, exceeding analyst estimates and showing year-over-year revenu...
Verona Pharma (NASDAQ:VRNA) Reports Q3 2024 Results with Promising Ohtuvayre™ Launch
November 04, 2024 12:07 AM PST| By Team Kalkine MediaHighlights:,Ohtuvayre™ generates $5.6 million in net sales in its first seven weeks, signaling a strong market entry.,October sales outpace Q3 performance with over 5,000 prescriptions filled.,Robust cash position of $336 million to support operation...
QIAGEN (NYSE:QGEN) Receives FDA Clearance for QIAstat-Dx Meningitis/Encephalitis Panel
November 04, 2024 12:05 AM PST| By Team Kalkine MediaHighlights:,QIAGEN secures fourth FDA clearance in 2024, enhancing its diagnostic offerings.,Rapid results in just one hour revolutionize the diagnosis of central nervous system infections.,Advanced technology provides detailed clinical insights with...
Coronation Fund Managers Reduces Stake in Revvity, Inc.
November 03, 2024 10:16 AM PST| By Team Kalkine MediaHeadlines,Coronation Fund Managers decreased its stake in Revvity, Inc. during the third quarter.,Major institutional investors are showing dynamic movements in their Revvity holdings.,Revvity sees significant interest from leading institutional fund...
Elevance Health Attracts Increased Institutional Investment
November 03, 2024 08:43 AM PST| By Team Kalkine MediaHeadlines,Coronation Fund Managers enhances Elevance Health stake,Notable hedge fund activity reflects confidence in Elevance Health,Elevance Health demonstrates strong financial metrics and stability,Coronation Fund Managers Ltd. has recently increa...
What Does the Performance of The Cooper Companies Tell Us?
October 30, 2024 07:06 AM PDT| By Team Kalkine MediaHighlights,The Cooper Companies experiences a significant increase in share price over the last year.,Long-term returns have not met market averages, raising questions about performance.,Revenue growth indicates management's focus may be on expansion...
Edwards Lifesciences (NYSE:EW) benefits from a rating upgrade by Sanford C. Bernstein
October 30, 2024 04:57 AM PDT| By Team Kalkine MediaHighlights,Edwards Lifesciences received an upgrade from "strong sell" to "hold" from Sanford C. Bernstein amid a challenging market environment.,The company reported earnings that met analyst estimates but experienced a decline in revenue compared t...
Eli Lilly's shares face a decline due to unmet quarterly profit estimates
October 30, 2024 04:17 AM PDT| By Team Kalkine MediaHighlights,Eli Lilly reported third-quarter profits that fell short of Wall Street estimates, primarily due to higher manufacturing costs and a substantial acquisition-related charge.,Sales of key products, Mounjaro and Zepbound, were lower than anti...
How Did BrainStorm Cell Therapeutics Regain Nasdaq Compliance?
October 30, 2024 04:07 AM PDT| By Team Kalkine MediaHighlights,BrainStorm Cell Therapeutics announces compliance with Nasdaq's listing requirements.,The company specializes in autologous stem cell therapies for neurodegenerative diseases.,Regaining compliance opens doors for continued market presence...
Vera Therapeutics (NASDAQ:VERA) receives a new price target of $64.00 from Guggenheim
October 30, 2024 03:45 AM PDT| By Team Kalkine MediaHighlights,Guggenheim has raised its price objective for Vera Therapeutics from $56 to $64, indicating potential upside for the stock.,The company specializes in developing treatments for serious immunological diseases, with its lead product candidat...
BrainStorm Cell Therapeutics successfully restores compliance with Nasdaq requirement
October 30, 2024 03:41 AM PDT| By Team Kalkine MediaHighlights,BrainStorm Cell Therapeutics Inc. has regained compliance with Nasdaq's minimum bid price requirement, ensuring continued listing on The Nasdaq Capital Market.,The company is recognized for its innovative autologous adult stem cell therapi...
Brooklyn ImmunoTherapeutics: Pioneering Innovation in Cancer Treatment
October 29, 2024 10:59 AM PDT| By Team Kalkine MediaHeadlines,Brooklyn ImmunoTherapeutics Gains Momentum,Innovative Treatments for Regenerative Medicine,Exploring New Horizons in Cancer Care,Brooklyn ImmunoTherapeutics (NYSE) has recently seen a positive shift in its stock performance, with an increas...
What Financial Challenges Does Evoke Pharma Face?
October 29, 2024 09:49 AM PDT| By Team Kalkine MediaHighlights,Evoke Pharma Inc. focuses on developing treatments for gastroenterological disorders.,The company is approaching a potential milestone toward profitability.,Concerns about financial stability and capital management remain prevalent.,Evoke...
Analysts Maintain Positive Outlook on AbbVie Inc
October 29, 2024 09:12 AM PDT| By Team Kalkine MediaHeadlines,Analysts have a favorable view of AbbVie Inc.,Recent price targets reflect strong confidence in the company.,Multiple upgrades highlight AbbVie's growth potential.,AbbVie Inc.,(NYSE:ABBV),continues to attract positive attention from analyst...
Global Cord Blood Gains Analyst Attention for Stem Cell Services
October 29, 2024 08:49 AM PDT| By Team Kalkine MediaHeadlines,Global Cord Blood Gains Analyst Attention,Key Services Offered by Global Cord Blood,Future Prospects of Global Cord Blood,Global Cord Blood,(NYSE:CO),has recently attracted interest from analysts who initiated coverage on the company. The b...
